Eisai's Leqembi receives Health Canada Notice of Compliance with Conditions

Eli Lilly and Incyte report strong one-year results for baricitinib in adolescents with severe alopecia areata

Jacabio reports pre-clinical data for JAB-23E73 pan-KRAS inhibitor at international conference

Spinogenix to present SPG601 Phase 2a trial results at AACAP Conference

Orion secures exclusive commercial licence for Abzena cancer antibody

FDA grants priority review for Merck's KEYTRUDA combinations with Padcev in muscle-invasive bladder cancer

Sanofi expands partnership with Dassault Systèmes' Medidata to accelerate development of new therapies

BioNxt Solutions advances toward 2026 human trials for sublingual multiple sclerosis drug

AnnJi Pharmaceutical secures FDA Fast Track Designation for AJ201 in rare neuromuscular disease

Myosin Therapeutics' MT-125 granted US FDA Fast Track designation in glioblastoma

Boehringer Ingelheim's JASCAYD (nerandomilast) IPF treatment gains Chinese regulatory approval

Eterna Health and Dr Adeel Khan Pioneer First Regenerative Treatment Using Small Pluripotent Stem Cells (SPSCs)

ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment

Galera Therapeutics sells dismutase mimetics portfolio to Biossil in USD108.5m agreement

Kyowa Kirin reports new registry data showing overall survival benefit with mogamulizumab in advanced CTCL